;
Skip to main content
Home > SciBX > Therapeutics

Chronological Index of : Therapeutics

 Current Issue
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute lymphoblastic leukemia (ALL) Lysine-specific demethylase 6A (KDM6A; UTX); KDM6B (JMJD3) Cell culture …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Neurofibromin 1 (NF1); MEK; suppressor of zeste 12 homolog (SUZ12); bromodomain containing 4 (…

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Junction plakoglobin (JUP) Studies in mice and patient samples suggest JUP inhibition could …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer BRAF; eukaryotic translation initiation factor 4A1 (eIF4A1); eIF4F; MEK Studies in patient samples, …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Pancreatic cancer K-Ras (KRAS) Mouse studies suggest inhibiting oxidative phosphorylation could help …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Pancreatic cancer L1 cell adhesion molecule (L1CAM; CD171) Studies in patient samples and mice suggest …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Solid tumors EPH receptor A3 (EPHA3) In vitro and mouse studies suggest EPHA3 antibodies could help treat …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Dermatology Alopecia Janus kinase (JAK) Mouse studies suggest JAK inhibitors could help treat alopecia areata (AA).…

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Mucopolysaccharidosis a-l-iduronidase (IDUA) Feline studies suggest intrathecal IDUA …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Hematology Anemia Acyl-CoA synthetase short-chain family member 2 (ACSS2); endothelial PAS domain protein 1 (EPAS1; …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Malaria Not applicable Studies of patient serum samples have identified antibodies targeting …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Sepsis Not applicable Mouse studies suggest fibroblastic reticular cell (FRC) therapy could help treat…

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Duchenne muscular dystrophy (DMD) Dystrophin (DMD) Mouse studies suggest clustered, …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Cognitive dysfunction Type I interferon receptor (IFN receptor) Mouse studies suggest neutralizing IFN …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Neurology Aquaporin-4 (AQP4); corticotropin-releasing factor 1 (CRF1); corticotropin-releasing factor …

    Published on 9/18/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Rheumatoid arthritis (RA) IL-4 (BSF1); fibronectin extra domain A (FnEDA) Mouse studies suggest …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer c-Myc (MYC); MYC associated factor X (MAX) In vitro and mouse studies have identified compounds that …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Epidermal growth factor receptor (EGFR) In vitro studies identified allosteric EGFR inhibitors that …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Not applicable Rodent, canine and human studies suggest intratumoral injection of spores from the …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Lung cancer K-Ras (KRAS); microRNA-34a (miR-34a) Mouse studies suggest nanoparticle delivery of siRNAs …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiomyopathy; heart failure Myosin heavy chain 7 cardiac muscle-b (MYH7) Mouse studies …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Thrombosis Ectonucleoside triphosphate diphosphohydro­lase 3 (ENTPD3; CD39L3) In vitro and …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Forkhead box O1 (FOXO1) Mouse studies suggest FOXO1 inhibition could convert …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Infertility Defensin b1 (DEFB1) Patient sample studies suggest increasing DEFB1 levels …

    Published on 9/11/2014
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Hepatic disease Complement receptor 2 (CR2); CD59; complement C5b-9 membrane attack complex (MAC) …

    Published on 9/11/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993